1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Therapy

What are the most profitable therapies? Market trends and strategies explained

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
1 vote

Global Therapy Industry 

The global therapy industry (one large revenue center of the pharma industry) involves treatments intended to protect from, cure or manage specific illnesses. The treatment of each therapeutic area and its specific conditions varies widely.

Therapy is usually decided on once the patient has been diagnosed with a specific medical condition or disease, though therapies may also be preventive measures. Therapies applied following diagnosis are either abortive or supportive. The former is a curative measure that seeks to inhibit development of the condition, while the latter relieves the patient’s suffering due to the symptoms of the disease without treating the condition itself.

Preventive therapies are used to safeguard people against disease; for example, vaccinations are used to prevent infections such as polio, smallpox and measles.

Market Trends

The combined market for medicines and therapies used in the treatment of disease is witnessing a slower rate of spending: in the five years up to 2010, spending on medicines grew by more than 6% yearly. However, in the five years up to 2015, the rate of growth is slowing to between 3% and 6%. Global spending on medicine and therapy in 2015 is forecast to reach $1.1 trillion, reports the IMS Institute for Healthcare and Informatics.

The market is to see increased spending on generic drugs, hitting almost 40% growth in 2015 or nearly doubling in a decade. Spending on brand-name medicines should drop by $120 billion in the five-year period ending in 2015.

Increased prevalence of type 2 diabetes, particularly in emerging markets such as China, Brazil and India, will see global spending on the disease rise 4%-7% through 2015, with oral antidiabetics increasingly favored. Spending on therapeutic medicine to treat asthma and chronic obstructive lung disease will drop from 9% in the five-year period ending in 2010 to 2%-5% from 2010 to 2015.

Therapy Spending Forecasts to 2015 *In US$ Billion 

Key Market Segments

According to a report by the IMS Institute for Healthcare Informatics, oncology will continue to hold the top spot in the therapies industry, with forecast revenue between $75 billion and $80 billion in 2015, representing a jump of more than $20 billion in a five-year period. Lipid regulators will fall from second to fourth place, reaching between $29 billion and $34 billion in the same period. Meanwhile, anti-diabetics will rise to second place at between $43 billion and $48 billion.

Respiratory agents are expected to remain the third-biggest seller, with a $5 billion to $10 billion increase on 2010 sales. Drugs to treat hypertension are forecast to rise to fifth place with an up to $6.5 billion increase in revenue. Overall, auto-immune drugs should see a substantial jump to reach between $27 billion and $32 billion by 2015.

HIV antivirals are expected to jump from tenth to seventh place with sales of between $20 billion and $24 billion by 2015. A substantial drop in market share is expected for antidepressants, from more than $20 billion in 2010 to between $13 billion and $16 billion in 2015.  Treatments for multiple sclerosis should rise several places in the same period, marking revenue from under $10 billion to between $12 billion and $15 billion. Antipsychotics are forecast to see a $5 billion drop to $20 billion in 2015.

Therapy segments expected to drop out of the top-20 list include vitamins and minerals, antirheumatics, cephalosporins, combs (antibiotics) and vaccines. Categories expected to appear in the top 20 include treatments for glaucoma, Alzheimer’s, osteoporosis and attention deficit hyperactivity disorder.

Categories expected to show less substantial fluctuation include narcotic analgesics, antiepileptics and erythropoietics.

Top 20 Global Therapeutic Categories (2015) 

Read more ยป

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 600 reports

Global Therapy Industry

  • June 2015
    32 pages
  • Therapy  

  • World  

    United Kingdom  

View report >

Therapy Markets in the US

  • December 2015
    102 pages
  • Therapy  

    Pharmaceutical  

  • United States  

View report >

Therapy Industry in Europe Forecast

  • January 2015
    8 pages
  • Genomics  

    Biomarker  

  • Europe  

View report >

Therapy Industry in Asia

  • January 2015
    10 pages
  • Therapy  

  • Asia  

    World  

View report >

Therapy Industry in Japan

  • January 2015
    5 pages
  • Therapy  

  • Japan  

    United States  

View report >

Therapy Industry in France and Europe

  • January 2013
    16 pages
  • Therapy  

  • France  

    Europe  

View report >

Therapy Industry in Germany

  • January 2014
    8 pages
  • Infectious Dise  

  • Germany  

View report >

Therapy Industry in Italy

  • January 2015
    9 pages
  • Therapy  

  • Italy  

    Europe  

View report >

Therapy Industry in the UK

  • September 2015
    76 pages
  • Nursing Home  

    Hospital  

  • United Kingdom  

    World  

    Europe  

View report >

Chemotherapy And Therapy Industry in Canada

  • September 2014
    77 pages
  • Chemotherapy  

    Therapy  

    Cancer  

  • Canada  

    United States  

View report >


About 3 000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 99 - $ 8 744)

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 7 695
  • Industry report
  • December 2015
  • by Firstword Pharma

ipeline drugs are poised to reshape the way doctors treat ulcerative colitis (UC). But where will new therapies fit into the UC treatment paradigm? How will they affect existing brands? And what will ...

Peptide Therapeutics Market: Global Industry Analysis A ...

November 2015 $ 7 500

Frontier Pharma: Ovarian Cancer - Identifying And Comme ...

December 2015 $ 6 995

Type 2 Diabetes Mellitus Therapeutics In Asia-pacific M ...

January 2016 $ 4 995

Breast Cancer Therapeutics In Major Developed Markets T ...

December 2015 $ 4 995

Pancreatic Cancer Therapeutics In Major Developed Marke ...

December 2015 $ 4 995

Global Immunology Market To 2022 - Large Pipeline And C ...

December 2015 $ 4 995

Copd Therapeutics In Major Developed Markets To 2021 - ...

November 2015 $ 4 995

Breast Cancer Therapeutics Market - Global Industry Ana ...

November 2015 $ 4 795

Radiotherapy Market By Technology, Brachytherapy, & Sys ...

January 2016 $ 4 650

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.